Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management
Public ClinicalTrials.gov record NCT05243511. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
"PROSPER-FM": Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
PROSPER-FM is a multi-center, randomized, non-significant risk device study to evaluate the safety and efficacy of two digital therapy smartphone applications in participants with fibromyalgia. Eligible participants are randomized (1:1) to either the Digital Acceptance and Commitment Therapy (Digital ACT) group or the Digital Symptom Tracker group and receive assigned therapy for 12 weeks.
Study identification
- NCT ID
- NCT05243511
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 275 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 8, 2022 (Actual)
- Primary completion
- May 15, 2023 (Actual)
- Completion
- May 15, 2023 (Actual)
- Last update posted
- Jun 15, 2023
2022 – 2023
United States locations
- U.S. sites
- 25
- U.S. states
- 12
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site #37 | Covina | California | 91722 | — |
| Site #15 | Oceanside | California | 92056 | — |
| Site #31 | San Bernardino | California | 92498 | — |
| Site #38 | Thousand Oaks | California | 91360 | — |
| Site #36 | Tujunga | California | 91042 | — |
| Site #35 | Whittier | California | 90602 | — |
| Site #13 | Orlando | Florida | 32801 | — |
| Site #33 | St. Petersburg | Florida | 33709 | — |
| Site #25 | Atlanta | Georgia | 30329 | — |
| Site #21 | Covington | Louisiana | 70433 | — |
| Site #20 | New Orleans | Louisiana | 70124 | — |
| Site #22 | Prairieville | Louisiana | 70769 | — |
| Site #39 | Chestnut Hill | Massachusetts | 02467 | — |
| Site #24 | Ocean Springs | Mississippi | 39564 | — |
| Site #34 | Brooklyn | New York | 11235 | — |
| Site #32 | Scarsdale | New York | 10583 | — |
| Site #12 | Williamsville | New York | 14221 | — |
| Site #27 | Fargo | North Dakota | 58104 | — |
| Site #14 | Cincinnati | Ohio | 45219 | — |
| Site #28 | Dayton | Ohio | 45419 | — |
| Site #23 | Tulsa | Oklahoma | 74133 | — |
| Site #16 | Allentown | Pennsylvania | 18104 | — |
| Site #29 | Austin | Texas | 78726 | — |
| Site #26 | McKinney | Texas | 75070 | — |
| Site #30 | Pflugerville | Texas | 78660 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05243511, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 15, 2023 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05243511 live on ClinicalTrials.gov.